Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Pushing ahead: Precision medicine, national leadership in lymphoma

Pushing ahead: Precision medicine, national leadership in lymphoma

Wilmot's lymphoma team is collaborating with experts in diverse fields to understand better how these cancers of the immune system behave, and their work is shaping the way lymphoma is treated around the world.

Gene Study Points Researchers toward New Pathway for Leukemia

Gene Study Points Researchers toward New Pathway for Leukemia

Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.

Pathologist Seeks Earlier Answers for Families with Lynch Syndrome

Pathologist Seeks Earlier Answers for Families with Lynch Syndrome

Lynch syndrome is one of the most common inherited conditions that raises a person’s risk of colorectal cancer. Pathologist Jennifer Findeis-Hosey, M.D., is looking for ways to identify clinical and pathological features of colon polyps that may indicate the condition before an individual at risk has developed cancer.